All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
South Hall 2 Wed, 30.03.2022 11:30 - 13:00

Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC (ID 33)

Time
11:30 - 13:00
Location
South Hall 2
Date
Wed, 30.03.2022
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

Welcome and introduction (ID 325)

Lecture Time
11:30 - 11:35
Speakers
  • Solange Peters, Lausanne, CH
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

KRASG12C inhibition: A major landmark in 2nd line treatment of patients with advanced NSCLC (ID 327)

Lecture Time
11:35 - 11:50
Speakers
  • Joop De Langen, Amsterdam, NL
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

The turning point: Practical considerations when emerging biomarkers become actionable (ID 328)

Lecture Time
11:50 - 12:05
Speakers
  • Keith M. Kerr, Aberdeen, GB
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

Forward thinking: Future perspectives in targeting KRAS in NSCLC (ID 329)

Lecture Time
12:05 - 12:20
Speakers
  • Solange Peters, Lausanne, CH
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

Managing patients with KRAS G12C-mutant NSCLC: Real-world perspectives (ID 330)

Lecture Time
12:20 - 12:35
Speakers
  • Keith M. Kerr, Aberdeen, GB
  • Solange Peters, Lausanne, CH
  • Joop De Langen, Amsterdam, NL
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

Live Q&A / discussion (ID 331)

Lecture Time
12:35 - 12:55
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

Summary and close (ID 332)

Lecture Time
12:55 - 13:00
Speakers
  • Solange Peters, Lausanne, CH
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00